Novel oximes

Details Novel oximes Novel oximes

1979-11-29

1981-10-27

Coughlan, Jr., Paul M.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

544 22, 544 27, A61K 31545

Patent

active

042973520

ABSTRACT:
Novel syn isomers of 3-substituted-7-amino-thiazolyl-acetamido-cephalosporanic acid compounds of the formula ##STR1## wherein R is selected from the group consisting of alkyl of 1 to 5 carbon atoms, cycloalkyl of 3 to 5 carbon atoms and --CH.sub.2 --S--R.sub.1, R.sub.1 is selected from the group consisting of 2-methyl-1,3,4-thiadiazolyl, 1-methyl tetrazolyl, acyl of an organic carboxylic acid of 2 to 4 carbon atoms and ##STR2## R.sub.2 is selected from the group consisting of alkyl and alkoxy of 1 to 4 carbon atoms and A is selected from the group consisting of hydrogen, alkali metal, alkaline earth metal, magnesium and a non-toxic, pharmaceutically acceptable organic amine having antibiotic activity and novel intermediates and process for their preparation.

REFERENCES:
patent: 4008246 (1977-02-01), Ochiai et al.
patent: 4024134 (1977-05-01), Gregson et al.
patent: 4098888 (1978-07-01), Ochiai et al.
Numata et al., Chem. Pharm. Bull., 25(11) 3117-3119 (1977).

Affiliated with

Also associated with

Rating

Novel oximes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel oximes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel oximes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-279404